Erwinase (erwinia L-asparaginase) For Injection - Replacement With UK Labelled Stock And Shortage
ERWINASE Recall Summary Erwinase (Erwinia L-asparaginase) for Injection is being recalled across Canada and replaced with stock labeled in the UK due to product safety concerns. This medication is used as part of cancer treatment protocols. The recall affects all patients and healthcare providers who have received or are using this drug in Canada.
- Reason
- Product safety
- Category
- drug recall
- Country
- Canada
- Agency
- HC-DRUGS
- Recall date
- 2016-08-02
- Status
- Closed
- Distribution
- Canada-wide
Official recall notice from HC-DRUGS
Recall details on Nibble Recalls: https://trynibble.app/recalls/38e4f7c8-b13d-451c-a1e6-cff1be5d9f6e